Jakob Dupont, M.D.
Board Member
Pyxis Oncology, Inc. (PYXS)Equibles does not estimate personal net worth.
Get an email with a short summary when Pyxis Oncology, Inc. publishes a filing, an earnings call transcript or a press release.
Get PYXS alertsAbout Jakob Dupont, M.D.
Jakob Dupont, M.D. is recorded as Board Member at Pyxis Oncology, Inc. (PYXS) since August 23, 2023. Pyxis Oncology, Inc. reported in an 8-K filed August 23, 2023 that Jakob Dupont, M.D. was appointed Class III director, effective August 23, 2023. Pyxis Oncology, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Pyxis Oncology, Inc. includes Thomas Civik (CEO, Chairman and Board Member), Pamela Connealy (COO), Jitendra Wadhane (Chief Accounting Officer) and 3 others.
“On August 23, 2023, effective as of the Effective Time, Jakob Dupont, M.D., a former director of Apexigen, was appointed to the Board as a Class III director and his term will expire at the annual meeting of stockholders to be held in 2024.”
Affiliation history
-
Current
2023-08-23–present
Company network
Leadership on record at Pyxis Oncology, Inc.
- Thomas Civik CEO, Chairman, Board Member
- Pamela Connealy COO
- Jitendra Wadhane Chief Accounting Officer
- Michael A. Metzger Board Member
- Rachel Humphrey, M.D. Board Member
- Santhosh Palani, Ph.D., CFA Board Member